Phosphodiesterase-5-inhibitors compared

被引：0
|
作者：
不详
机构：
来源：
AKTUELLE UROLOGIE | 2005年 / 36卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Review of Combined Phosphodiesterase-5-Inhibitors and α-Blockers versus Phosphodiesterase-5-Inhibitors Alone for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
    Jackson, Elizabeth M.
    Khooblall, Prajit
    Lundy, Scott D.
    Bajic, Petar
    ARAB JOURNAL OF UROLOGY, 2024, 22 (01) : 13 - 23
  • [2] Low-dose phosphodiesterase-5-inhibitors have a distinct effect on hepatic hemodynamics
    Halverscheid, Leonie
    Deibert, Peter
    Dunkem, Torsten
    Schmidt, Rene
    Pannen, Benedikt H.
    Kreisel, Wolfgang
    GASTROENTEROLOGY, 2008, 134 (04) : A221 - A221
  • [3] Modulation of doxorubicin-induced enclothelin-1 expression by phosphodiesterase-5-inhibitors
    Oetjen, B.
    Bien, S.
    Ritter, C. A.
    Kroemer, H. K.
    EJC SUPPLEMENTS, 2007, 5 (04): : 79 - 79
  • [4] Synthetic phosphodiesterase-5-inhibitors use/abuse and interest of hair testing: reporting of a rape case
    Duez, Mathieu
    Etter, Matthieu
    Klinger, Nadine
    Cirimele, Vincent
    DRUG TESTING AND ANALYSIS, 2014, 6 : 17 - 21
  • [5] Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction
    Uschner, Frank E.
    Glueckert, Kathleen
    Paternostro, Rafael
    Gnad, Thorsten
    Schierwagen, Robert
    Mandorfer, Mattias
    Magdaleno, Fernando
    Ortiz, Cristina
    Schwarzkopf, Katharina
    Kamath, Patrick S.
    Alessandria, Carlo
    Boesecke, Christoph
    Pfeifer, Alexander
    Reiberger, Thomas
    Kreisel, Wolfgang
    Sauerbruch, Tilman
    Ferlitsch, Arnulf
    Trebicka, Jonel
    Klein, Sabine
    LIVER INTERNATIONAL, 2020, 40 (09) : 2228 - 2241
  • [6] Outpatient Evaluation and Follow-Up of Veterans with Group 3 Pulmonary Hypertension Treated with Phosphodiesterase-5-Inhibitors
    Johnson, S. W.
    Gillmeyer, K. R.
    Qian, S.
    Klings, E. S.
    Wiener, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] Influence Of 'out Of Network' Pulmonary Hypertension Care And Va Pharmacy Consultation On Potentially Inappropriate Prescribing Of Phosphodiesterase-5-Inhibitors In The Va
    Freiman, M. R.
    Rose, A. J.
    Miller, D.
    Wiener, R. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [8] Phosphodiesterase 5 inhibitors
    Stamford, AW
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 : 53 - 64
  • [9] Phosphodiesterase 5 inhibitors
    Faure, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2013, 52 (530): : 51 - 54
  • [10] Factors Associated with Guideline-Discordant Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension Among US Veterans, 2006-2015
    Gillmeyer, K. R.
    Lee, K. M.
    Shao, Q.
    Glickman, M. E.
    Hanlon, J. T.
    Miller, D. R.
    Rinne, S. T.
    Klings, E. S.
    Maron, B. A.
    Wiener, R. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345